Résultats de la recherche
10
Tout
Medigene AG Expands Patent Portfolio with Patent Grant for its JOVI Technology in the U.S.
19 févr. 2025 05h00 HE
|
Medigene AG
Planegg/Martinsried, February 19, 2025. Medigene AG (Medigene, FSE: MDG1, Prime Standard) , an oncology platform company focused on the research and development of T cell receptor (TCR)-guided...
Master IP Due Diligence & Freedom to Operate: Online Training Course on Best Practices for IP Analysis, Mergers & Acquisitions, and Risk Mitigation – March 6-7, 2025
17 févr. 2025 10h08 HE
|
Research and Markets
Dublin, Feb. 17, 2025 (GLOBE NEWSWIRE) -- The "IP (Intellectual Property) Due Diligence & Freedom to Operate in Practice Training Course (ONLINE EVENT: March 6-7, 2025)" has been added to ...
Medigene AG Expands Protection of its KRAS Library with Filing of New Patent Application Supporting MDG2021
25 sept. 2024 03h00 HE
|
Medigene AG
Planegg/Martinsried, September 25, 2024 – Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor...
Hybrid Bonding Patent Landscape Analysis 2024: Key Players' IP Position and IP Strategy - Focus on TSMC, Adeia/Xperi, TongFu and ASE
06 sept. 2024 06h38 HE
|
Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Hybrid Bonding - Patent Landscape Analysis 2024" report has been added to ResearchAndMarkets.com's offering. Hybrid bonding technology emerged in...
Medigene AG Secures Two Additional Patents for Technologies in Its End-to-End Platform
29 août 2024 05h00 HE
|
Medigene AG
Planegg/Martinsried, August 29, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor...
Senior Trade Mark & Design Administrators Annual Update Training Course: Explore the Differences Between EU, US, UK and Foreign Design Filing Practices (ON-DEMAND)
18 juil. 2024 06h19 HE
|
Research and Markets
Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "Annual Update for Senior Trade Mark & Design Administrators Training Course" conference has been added to ResearchAndMarkets.com's offering. This...
Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety and Efficacy, In Vivo
04 mars 2024 02h00 HE
|
Medigene AG
Planegg/Martinsried, March 4, 2024. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid...
GaN Electronics Patent Landscape Report 2023: Key Trends and Strategies in Power and RF Applications Across Global Markets
20 févr. 2024 07h50 HE
|
Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "GaN Electronics Patent Landscape Analysis 2023" report has been added to ResearchAndMarkets.com's offering. The market research catalog is an...
SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO
04 janv. 2024 09h00 HE
|
SINTX Technologies, Inc.
SALT LAKE CITY, Jan. 04, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT; “SINTX” or the “Company”), a manufacturer and developer of advanced ceramic materials and...
Medigene AG Expands Patent Portfolio for its End-to-End Platform
22 mai 2023 09h00 HE
|
Medigene AG
Planegg/Martinsried, May 22, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid...